An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies

Conditions:   Advanced Solid Tumor;   Lymphoma Intervention:   Drug: ALPN-202 Sponsor:   Alpine Immune Sciences, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials